ESR1 and breast cancer: Yu H et al. (Yu et al., 2019), observed that transferrin receptor (TFRC) expression was significantly higher in ER-tissues compared to ER + tissues, and knockdown of estrogen receptor (ER) increased TFRC expression in BC cells.